Gordon Keller is the director of the McEwen Stem Cell Institute at the University Health Network in Toronto, Canada. He is also a senior scientist at Princess Margaret Cancer Centre and a professor in the Department of Medical Biophysics at the University of Toronto. Keller is the premier researcher in the application of developmental biology–guided principles to the differentiation of pluripotent stem cells into therapeutically relevant cells, such as cardiomyocytes, hematopoietic cells, and liver cells.

A world-renowned stem cell scientist, Keller was selected by an independent committee of international stem cell experts for his contributions to efficient lineage-specific differentiation of human pluripotent stem cells into a myriad of cell types, enabling disease modeling and regenerative medicine approaches for many human diseases.

Due to limited seating this event is first-come, first served for Gladstone and USCF community members. If you cannot join us in person, register to watch the livestream.

The Ogawa-Yamanaka Stem Cell Prize recognizes individuals whose original translational research has advanced cellular reprogramming technology for regenerative medicine. Supported by the Gladstone Institutes, the prize was established in 2015 through a generous gift from the late Betty and Hiro Ogawa and has been maintained through their sons, Andrew and Marcus Ogawa. In honor of the Ogawas’ continuing philanthropic legacy, the prize recognizes the importance of induced pluripotent stem cells (iPSCs), discovered by Gladstone Senior Investigator and Nobel laureate Shinya Yamanaka, MD, PhD. This year, Gladstone formed a partnership with the Cell Press group to support this important prize.